Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 8:30 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2305–2328 of 21,042 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Oral Surgery
Interventions: Vicodin, Dexamethasone; Drug
Lead sponsor: Boston University; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Postbariatric Hypoglycemia
Interventions: exendin 9-39, Placebo; Drug · Other
Lead sponsor: Eiger BioPharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 5
States / cities: Palo Alto, California • Aurora, Colorado • Baltimore, Maryland + 2 more

Conditions: Stress Hyperglycemia
Interventions: Dulaglutide Injection, Saline Injection; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Malnutrition, Anemia
Interventions: MNP; Dietary Supplement
Lead sponsor: Columbia University; Other
Eligibility: 6 Months to 54 Months
Enrollment: 526 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Major Depressive Disorder
Interventions: Slow-wave deprivation; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 35 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Osteoarthritis
Interventions: Synvisc-One (G-F 20); Device
Lead sponsor: Anthony Luke; Other
Eligibility: 30 Years to 50 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Neurofibromatosis 1
Interventions: Letters about NF1 Care (Content Type 1), Letters about NF1 Care (Content Type 2); Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Not listed
Enrollment: 294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: PTSD
Interventions: Cognitive Processing Therapy, Stellate Ganglion Block; Behavioral · Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiac Dysfunction
Interventions: Echocardiogram; Diagnostic Test
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: Up to 18 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Alzheimer Disease, Healthy Aging
Interventions: BrightGo cognitive training, Standard of Care medication for early Alzheimer's Disease; Device · Drug
Lead sponsor: Bright Cloud International Corp; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: New Brunswick, New Jersey • North Brunswick, New Jersey

Conditions: Obstructive Sleep Apnea (OSA)
Interventions: C-Lift; Device
Lead sponsor: Ata Murat Kaynar; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Non-Small Cell Lung Cancer
Interventions: oxaliplatin, gemcitabine, bevacizumab; Drug
Lead sponsor: Mt. Sinai Medical Center, Miami; Other
Eligibility: 18 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Miami Beach, Florida

Conditions: Prostate Cancer
Interventions: GTx-758 125 mg, GTx-758 250 mg; Drug
Lead sponsor: GTx; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 26
States / cities: Burbank, California • Los Angeles, California • San Bernardino, California + 21 more

Conditions: Oxygen Toxicity
Interventions: Ketogenic food products; Dietary Supplement
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 39 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Surgical Wound Infection
Interventions: Chlorhexidine gluconate (4%), Mupirocin 2% Ointment; Drug
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years and older
Enrollment: 848 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Marlton, New Jersey

Conditions: Myelomeningocele
Interventions: Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix, Untreated contemporaneous cohort; Biological · Other
Lead sponsor: University of California, Davis; Other
Eligibility: 19 Weeks to 25 Weeks
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Hypertension
Interventions: Salt loading, Hydrochlorothiazide (HCTZ); Procedure · Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 65 Years
Enrollment: 124 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Lancaster, Pennsylvania

Conditions: Human Immunodeficiency Virus
Interventions: Cognitive-Based Compassion Training (CBCT), Health discussion; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Sleep
Interventions: transcranial direct current stimulation (tDCS), Sham; Device · Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 60 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Diabetes
Interventions: team-based care; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pain, CYP2D6 Polymorphism
Interventions: CYP2D6, Brief Pain Inventory-Short Form (BPI-SF), M.D. Anderson Symptom Inventory (MDASI), OPRM1; Genetic · Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 120 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 2
States / cities: Gainesville, Florida • Tampa, Florida

Conditions: Overweight and Obesity, Overweight, Obesity
Interventions: Nudge; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 35 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: CLL / SLL, CLL (Chronic Lymphocytic Leukemia), SLL (Small Lymphocytic Lymphoma), Marginal Zone Lymphoma(MZL), Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
Interventions: Lonitoclax (ZE50-0134); Drug
Lead sponsor: Lomond Therapeutics Holdings, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 5
States / cities: Louisville, Kentucky • Chapel Hill, North Carolina • Cincinnati, Ohio + 2 more

Conditions: Hormone Care, Mild Depression, Anxiety
Interventions: Peer support group, Enhanced Usual Care (EUC); Behavioral · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

Pilot Study: Effect of Dexamethasone vs Vicodin in Reducing Post-operative Pain

Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia

Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

Microfinance Institutions as a Platform for Global Health

Slow-wave Sleep Deprivation in Depression

Synvisc-One for Younger, Active Patients With Osteoarthritis

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

Evaluating The Efficacy Of Combined Cognitive Processing Therapy and Stellate Ganglion Blocks for PTSD

Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient

Telerehabilitation Alzheimer's Disease Feasibility (TADF)

C-LIFT Efficacy in Patients With Obstructive Sleep Apnea

Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

Effects of Pre-dive Ketone Food Products on Latency to CNS Oxygen Toxicity (Aim 1)

The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal

Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial

Salt Loading and Thiazide Intervention Study

Cognitive-Based Compassion Training (CBCT) for People Living With HIV (PLHIV)

The Effect of tDCS Applied During Sleep on Memory Consolidation

Comprehensive Intervention to Evaluate Outcomes AND Cost in Hospitalized Surgical Patients With Diabetes Mellitus (DM)

Precision Medicine Guided Treatment for Cancer Pain

Precision Public Health: Enhancing Connections to Develop Just-in-Time Adaptive Intervention Strategies

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

Feasibility and Acceptability of Peer Intervention for Improving Mental Health Among People Accessing Hormone Care